REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Rct Drug Corporation (Philippines)

Main Activities: Pharmacies and Drug Stores
Full name: Rct Drug Corporation Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Rct Drug Corporation is an enterprise based in Philippines. Its main office is in City Of San Fernando. The company operates in the Pharmacies and Drug Stores industry. The company was established on September 07, 1993. The latest financial highlights indicate a net sales revenue drop of 8.95% in 2024. There was a total negative growth of 25.62% in Rct Drug Corporation’s total assets over the same period.

Headquarters
451 Consunji St., Sto. Rosario Pampanga
City Of San Fernando;

Contact Details: Purchase the Rct Drug Corporation report to view the information.

Basic Information
Financial Auditors:
Purchase the Rct Drug Corporation report to view the information.
Incorporation Date:
September 07, 1993
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Chairman;Treasurer
Ownership Details
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Rct Drug Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-8.95%▼
Total operating revenue
-8.95%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
-25.62%▼
Total Equity
-24.37%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.04%▲
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo